Previous close | 25.06 |
Open | 25.06 |
Bid | 24.44 x 300 |
Ask | 24.54 x 300 |
Day's range | 23.11 - 25.22 |
52-week range | 20.84 - 34.28 |
Volume | |
Avg. volume | 1,095,196 |
Market cap | 2.553B |
Beta (5Y monthly) | 0.48 |
PE ratio (TTM) | 23.35 |
EPS (TTM) | 1.05 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 43.60 |
Corcept Therapeutics ( NASDAQ:CORT ) First Quarter 2024 Results Key Financial Results Revenue: US$146.8m (up 39% from...
Corcept (CORT) beats on both earnings and sales in the first quarter of 2024. The company increases revenue guidance for 2024.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]